Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. - Wikidata - wikimedia - TriplyDB

Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.

Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.

http://www.wikidata.org/entity/Q42572244

about

Gene therapy for ischemic heart disease VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis Endothelial fatty acid transport: role of vascular endothelial growth factor B Receptor tyrosine kinase-mediated angiogenesis Vascular endothelial growth factor-B in physiology and disease Blood vessels as targets in tumor therapy Molecular regulation of tumor angiogenesis and perfusion via redox signaling.VEGF-B: a survival, or an angiogenic factor?Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis.Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.Coronary Artery Development: Progenitor Cells and Differentiation Pathways.VEGF-B: a thing of beauty.Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis.The Andean adaptive toolkit to counteract high altitude maladaptation: genome-wide and phenotypic analysis of the Collas.VEGF-C and aortic cardiomyocytes guide coronary artery stem development.Targeting angiogenesis in esophagogastric adenocarcinoma.AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish.Cell and gene therapy approaches for cardiac vascularization.Dual gene transfer of bFGF and PDGF in a single plasmid for the treatment of myocardial infarction.Angiogenesis in the infarcted myocardium.Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease.Clinical Effect of Cardiac Shock Wave Therapy on Myocardial Ischemia in Patients With Ischemic Heart Failure.Lack of cardiac and high-fat diet induced metabolic phenotypes in two independent strains of Vegf-b knockout mice.VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications.Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons.Methylation patterns of Vegfb promoter are associated with gene and protein expression levels: the effects of dietary fatty acids.VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters.Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats.Vascular endothelial growth factor-B: Impact on physiology and pathology.Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.Endothelium-specific overexpression of human vascular endothelial growth factor-D in mice leads to increased tumor frequency and a reduced lifespan.Vascular Endothelial Growth Factor B and Its Signaling.

P2860

Q24632135-6F3EC7D0-D8E5-474E-AECD-162A080F3860 Q24658393-5E0AE31C-0FC1-4F5B-8D23-B5A8E44E04EF Q26796921-792F29CA-E8B5-40F1-8137-414580CEB29A Q26829121-75829740-CC60-460B-9F51-9FBBD3534712 Q27001612-E0CFE604-CEF0-4DC1-AF95-BD08268137CE Q27003400-80CCCFDD-BA8B-485F-B14F-A1866474D5CA Q28590737-16A2512C-DB31-40CE-859B-04BDF2FAE2D9 Q33572306-020294B0-213E-4C96-82BA-A2071BA22916 Q33575959-989E52EE-4901-4650-9D65-EC249518A27C Q33616384-75975497-C065-4FBB-B6D1-3844844FD169 Q33834038-CFC16F54-2B9A-41ED-93EF-D52989AD21BD Q33909846-40B29235-674D-481B-A8F7-75E37978FA86 Q34147334-0A1F1E3A-CCCB-4475-ABCE-4C0A1AB43004 Q34487229-A051D90B-6DA4-499E-8F00-C71F7C8AA79C Q35136029-C80B8555-F28A-497A-A663-D287B74422C3 Q35140087-D86C10F1-EFC8-4D7F-AD22-B6EEB3EF6389 Q35584958-7D765FD7-EDF3-48F4-86D2-CFAD9A7CBA0E Q36460444-B468AE86-0AE2-497F-B85E-6B25FE54CCE2 Q36557136-6BB920FF-9483-4C6A-81DA-2CEA47EFADF3 Q36666830-FAFD14B0-1069-458F-8800-8C77609E02BD Q37137760-B6B84840-7282-462E-95F8-590CFEFC7906 Q37512327-A50EFA28-5110-4683-B524-C18C4104205D Q37574875-41BAE809-BB4A-4C3E-992F-0906542B9505 Q38032602-41C48CAD-B0F3-44E9-8E87-70B62A1F225B Q38418718-DBA3A728-E05F-4576-9C5B-C1458E429BFC Q40221365-72EFDE3A-79CA-4EE0-BDD4-28CB873FC9BA Q42137101-72AC6F23-4B58-40DD-B92D-BE48273173F9 Q42491822-EB7914F4-9D34-40DA-AD88-DF7F6E06C673 Q42719160-60C034FC-EDFC-4039-9A7C-F2740C6B6ACC Q42816203-56615C4E-EA46-41F8-8846-1F65050DBA20 Q45257013-030C49D6-F384-41D2-B8D3-E7E0787B63FA Q45863064-311FB65E-0DF2-4CDA-8EE1-A8915B6EE748 Q47450318-F0CF1CFC-D445-48CE-AD11-180A32601723 Q52558418-9C4938C3-BBD2-45E8-AA01-DD567770AED8 Q54326793-AEBFBBDC-93DB-4AAF-AF87-E8525DE513ED Q55379904-571B894B-7C4A-424D-8908-10048704AEB8

P2860

Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.

http://www.wikidata.org/entity/Q42572244

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Reevaluation of the role of VE ...... on of the ischemic myocardium.

@en

Reevaluation of the role of VE ...... on of the ischemic myocardium.

@nl

type

label

Reevaluation of the role of VE ...... on of the ischemic myocardium.

@en

Reevaluation of the role of VE ...... on of the ischemic myocardium.

@nl

prefLabel

Reevaluation of the role of VE ...... on of the ischemic myocardium.

@en

Reevaluation of the role of VE ...... on of the ischemic myocardium.

@nl

P1433

Q42572244-5F9F076A-865D-46DD-8860-C5BEBB22A7EB

P1476

Q42572244-47617057-6E15-4A65-86F3-C11AC5B220F4

P2093

Q42572244-063DE266-2CDD-4FB3-9D6A-905E2F9D52CB

Q42572244-19A61D92-D05B-49F7-8E9A-FD3D19A97787

Q42572244-416C71BF-8F21-4FA4-AE2C-5F5B4B5CCC40

Q42572244-4A3D2CEE-3661-4D10-821B-E9B15F1D51F7

Q42572244-5B50FF45-F57E-4378-87B3-80AA8E304442

Q42572244-5B9A27CA-E1E5-44DD-97EF-9C8D97DA7682

Q42572244-5D9A00C4-6FD8-413B-B996-701F7F210087

Q42572244-74D611FA-E47C-4E9B-AB14-C29688CA73C6

Q42572244-7650E520-5D8E-44F2-ACEC-CDDC0321CCF4

Q42572244-87B46295-17F2-405B-9449-B14236497203

P2860

Q42572244-00229968-DD4C-47D1-AF4E-62B36EA1D034

Q42572244-00EBAB26-3CD3-497B-AAB6-202B5CF1AEE5

Q42572244-041FE5EA-D9EF-4A7D-9C59-1B450FD93643

Q42572244-1129E32C-84E6-4E4B-94A2-4F27CFFDE083

Q42572244-14FBDEB5-1D71-4C7E-8D89-0FD97E71C9B0

Q42572244-1D1BA5A7-4B87-4D7E-AA46-EDB9BD44680F

Q42572244-2A05994A-FF59-4720-B89C-66B40E588583

Q42572244-3880C765-BE32-442C-97D4-F1BE5A5C4881

Q42572244-492FAC43-9DC2-4622-A018-45EF7929D890

Q42572244-4C4EFE94-A669-47F9-8578-49264B299112

P304

Q42572244-DC12BC1B-A410-411C-AEC8-BA3A58ACEAF6

P31

Q42572244-6D7E2807-FAD9-4CA1-B5E3-D1A3B9EEFBC2

P356

Q42572244-2F29B074-7AB6-48E8-9918-5665A373B453

P407

Q42572244-A2179476-A3A3-48B0-91BA-334596F291DC

P433

Q42572244-91EFC79C-D763-40E1-8996-78526600D288

P478

Q42572244-2D20F3C9-CDFD-4913-BDCC-25864DEC6B7F

P50

Q42572244-0AEAF42C-BBBB-4CA1-9DB2-02194F5DCD7D

Q42572244-2BF2F744-54E7-4F5C-8300-33E8A83E0E85

Q42572244-2C7A2A36-0D59-4427-A6CC-1E1BE6D5E8D2

Q42572244-2D30DDF0-2B9B-47BF-B9BA-EA28A3209FDD

Q42572244-4BF94DA9-9660-4772-A712-6677421EA24D

Q42572244-C4453237-6FF8-4DD6-834F-83AABF091322

P577

Q42572244-1FF2E811-F56C-42D2-B785-1B38835532C2

P698

Q42572244-DB656278-83AD-4A59-B9DD-CBAEE893E792

P921

Q42572244-130FF4B0-A3AA-4D03-AF26-1150604E0192

P932

Q42572244-3F3F9E50-FD28-4F57-94B4-7B2462987BCB

P356

ATVBAHA.107.158725

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Reevaluation of the role of VE ...... on of the ischemic myocardium.

@en

P2093

Berndt Enholm

http://www.w3.org/2001/XMLSchema#string

Elke Neven

http://www.w3.org/2001/XMLSchema#string

Emmanuel Chorianopoulos

http://www.w3.org/2001/XMLSchema#string

Georges von Degenfeld

http://www.w3.org/2001/XMLSchema#string

Helen M Blau

http://www.w3.org/2001/XMLSchema#string

Hiromichi Wada

http://www.w3.org/2001/XMLSchema#string

Karri Paavonen

http://www.w3.org/2001/XMLSchema#string

Lieve Moons

http://www.w3.org/2001/XMLSchema#string

Maarten Vanwildemeersch

http://www.w3.org/2001/XMLSchema#string

Marc Tjwa

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

Angiogenesis in life, disease and medicine

Angiogenesis as a therapeutic target

Vascular endothelial growth factor-B promotes in vivo angiogenesis.

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

P304

1614-1620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.107.158725

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Michael Jeltsch

Peter Carmeliet

Jean-Michel Foidart

P577

2008-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18511699

http://www.w3.org/2001/XMLSchema#string

P921

revascularization

P932

2753879

http://www.w3.org/2001/XMLSchema#string